Delivery Order SPE2DB22D2006-SPE2DB24FV9ME

Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $52K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a ceiling value of $2,954.06 and a period of performance through March 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $5,102.97, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a $9,859.73 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 0.25-0.5 mg/dose pens. This delivery order contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The $1,451.30 award has an ultimate completion date of April 8, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as the sole contractor. The IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml. The contract has a ceiling value of $10,190.52 and a period of performance through September 12, 2024. This delivery order is placed against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $1,952.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This contract has an ultimate completion date of August 21, 2024 and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,103.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,741.62 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables Amerisourcebergen to efficiently deliver a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has a ceiling value of $2,169.03 and is set to expire on April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and received this award as part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a $11,610.44 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FV9ME
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 0.25-0.5 mg/dose pens. The award, valued at $51,508.23, has an ultimate completion date of April 15, 2024. This order is being issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 7/12/24, 10:46 AM